Prothrombotic Risk Factors in Patients with Thrombangitis Obliterans
- 1 September 2000
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 99 (5) , 483-486
- https://doi.org/10.1016/s0049-3848(00)00266-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Venous Thromboembolic Disease and the Prothrombin, Methylene Tetrahydrofolate Reductase and Factor V GenesThrombosis and Haemostasis, 1999
- Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease (endarteritis obliterans)Journal of Vascular Surgery, 1999
- Single and Combined Prothrombotic Factors in Patients With Idiopathic Venous ThromboembolismArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical resultsJournal of Vascular Surgery, 1998
- MICA gene polymorphism in Takayasu's arteritis and Buerger's diseaseInternational Journal of Cardiology, 1998
- Pathology and pathogenesis of Buerger's diseasePublished by Elsevier ,1998
- Antiendothelial Cell Antibodies in Thromboangiitis ObliteransThe Lancet Healthy Longevity, 1998
- Factor V Leiden and ThrombophiliaArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- A point scoring system for the clinical diagnosis of B uerger's diseaseEuropean Journal of Vascular and Endovascular Surgery, 1996
- Prävalenz der Hyperhomocysteinämie bei der Thrombangiitis obliterans: Spielt Homocystein pathogenetisch eine Rolle?Deutsche Medizinische Wochenschrift (1946), 1996